Lv51
1570 积分 2021-09-09 加入
Metabolic and Functional Cross Talk Between the Thyroid and Liver
23天前
已完结
Metabolic dysfunction-associated steatotic liver disease in adults
1个月前
已完结
Management of patients with type 2 diabetes and MASLD: an overview and joint statement
1个月前
已完结
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
1个月前
已完结
Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease
1个月前
已完结
Impact of sodium glucose cotransporter 2 inhibitor on histological features and glucose metabolism of non‐alcoholic fatty liver disease complicated by diabetes mellitus
1个月前
已完结
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
1个月前
已完结
Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and dipeptidyl peptidase‐4 inhibitors in improvement of fatty liver index in patients with type 2 diabetes mellitus and metabolic dysfunction‐associated steatotic liver disease: A retrospective nationwide claims database study in Japan
1个月前
已完结
Sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) plus glucagon‐like peptide type 1 receptor combination is more effective than SGLT2i plus dipeptidyl peptidase‐4 inhibitor combination in treating obese mice metabolic dysfunction‐associated steatotic liver disease (MASLD)
1个月前
已完结
Synergistic association of sodium-glucose cotransporter-2 inhibitor and metformin on liver and non-liver complications in patients with type 2 diabetes mellitus and metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Uric acid detection by means of SERS spectroscopy on dried Ag colloidal drops
6个月前
已采纳
Economic Evaluation of Rituximab Versus Corticosteroid‐Cyclophosphamide or Cyclosporine in Patients With Membranous Nephropathy in Republic of Korea
6个月前
已采纳
Targeted pH-Activated Peptide-Based Nanomaterials for Combined Photodynamic Therapy with Immunotherapy
6个月前
已采纳
皖公网安备34019202002308
